Previous 10 | Next 10 |
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced expansion of its pediatric offerings with the U.S. Food and Drug Administration (FDA) 510(k) clearance of the OrthoNext ™ digital platform, the only so...
Image source: The Motley Fool. Orthofix Medical Inc (NASDAQ: OFIX) Q1 2021 Earnings Call Apr 30, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Orthofix Medical Inc (OFIX) Q1 2021 Earnings Call Transcript
Orthofix Medical Inc. (OFIX) Q1 2021 Earnings Conference Call April 30, 2021 08:30 AM ET Company Participants Alexa Huerta – Senior Director-Investor Relations Jon Serbousek – President and Chief Executive Officer Doug Rice – Chief Financial Officer Conference Call Partic...
Orthofix (OFIX): Q1 Non-GAAP EPS of $0.17 beats by $0.15; GAAP EPS of -$0.30 misses by $0.16.Revenue of $105.59M (+0.7% Y/Y) beats by $9.98M.CEO comment: “Looking forward into 2021, we plan to continue to generate commercial momentum and execute future product launches to drive growth....
Net sales of $106 million, up 1% compared to prior year, after a strong recovery in March U.S. Spinal Implants net sales grew 19% compared to prior year, as net sales increased for both Spine Fixation and Motion Preservation Performed the first cervical and...
Orthofix to pursue FDA approval of IGEA’s solutions to expand the Company’s US Bone Growth Therapy offerings Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced they have entered into ...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that it plans to release financial results for the first quarter 2021 before market open on Friday, April 30, 2021. Jon Serbousek, President and Chief Executive Offic...
Orthofix Medical (OFIX) announces the FDA 510(k) clearance and first patient implant of the FORZA Ti TLIF Spacer System.Developed to help optimize Transforaminal Lumbar Interbody Fusion ((TLIF)) procedures, the FORZA Ti Spacer with Nanovate Technology is a titanium 3D-printed interb...
Designed for TLIF procedures, the 3D-printed FORZA Ti Spacer System further expands the comprehensive line of PEEK, PTC, and now Titanium interbody solutions offered by Orthofix for transforaminal lumbar applications Orthofix Medical Inc . (NASDAQ:OFIX), a global medical...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips A lot of the success of 3D stocks relates to the growing application of 3D bioprinting in the healthcare industry. As 3D printing technology becomes more accepted among the medical community, there’s a real opportuni...
News, Short Squeeze, Breakout and More Instantly...
Orthofix Medical Inc. Company Name:
OFIX Stock Symbol:
NASDAQ Market:
Orthofix Medical Inc. Website:
Wednesday, August 14, 2024 at 2:30 pm Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to pre...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716004...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone ™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or ma...